Inger Sandlie • 1953 • Oslo • 7 roles • 6 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Boards

Name	Role	Total operating income	Total equity	Shares
S SANDLIE AS	Chairman	-	-128,903	100 % directly
J JTIS AS Closed	Board Member	-	-1,767	33 % indirectly
A AUTHERA AS	Board Member	18,061,923	13,048,813	9.7 % indirectly
A AUTHERA HOLDING AS	Board Member	-	72,587	9.7 % indirectly
I INVEN2 AS	Board Member	81,443,000	163,208,000	-
R RADFORSK INVESTERINGSSTIFTELSE	Board Member	5,374,000	81,697,000	-
S SUPERIO BIO AS	Chairman	371,500	1,977	-

Last update: Jun 26, 2025

Related industries2

Direct relationships5

JT
Jan Terje Andersen1978
AUTHERA AS, JTIS AS, AUTHERA HOLDING AS, SUPERIO BIO AS
SM
Simone Mester1993
AUTHERA AS, AUTHERA HOLDING AS
TT
Torleif Tollefsrud Gjølberg1993
AUTHERA AS, AUTHERA HOLDING AS
BE
Benedicte Elisabeth Bakke Agerup1964
INVEN2 AS
TE
Tom Edward Pike1960
INVEN2 AS

Shares owned by Inger Sandlie

Name	Share class	Total operating income	Total equity	Share
S SANDLIE AS	Ordinære aksjer	0	-128,903	100 % directly
J JTIS AS Closed		0	-1,767	33 % indirectly
A AUTHERA AS		18,061,923	13,048,813	9.7 % indirectly
A AUTHERA HOLDING AS		0	72,587	9.7 % indirectly
N NEXTERA AS	NO0010848534	2,660,965	11,807,666	0.67 % directly < 0.01 %
N NYKODE THERAPEUTICS ASA	NO0010714785	9,158,000	140,142,000	0.02 % directly < 0.01 %

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025